|
You are not signed in
|
|
|
|
|
|
|
CME Events Schedule - Series Event Details
category view | day view | week view | monthly calendar view | search | |||
| FMC Cancer - General Tumor Board Conference Series | |||
| When: | Time: | 12:00 pm - 1:00 pm | |
| Location: | FMC Cancer Center Conference Room | ||
| Oncotype DX Colon Cancer Assay: Personalizing Risk Assessment in the Management of Stage II Colon Cancer | |||
| Presenter: | David H. Gibbs, Md, FASCRS | ||
| Objectives: |
|
||
| Teleconferenced: | No | ||
| Target Audience: | All physicians and healthcare professionals having an interest in the topic. | ||
|
|||
| CME Credit: | Category 1 | Hours: | 1 |
Accreditation Statement Novant Health is accredited by the North Carolina Medical Society to sponsor continuing medical education for physicians. CME Credit: Disclosure Novant Health designates the above educational activity for up to 1 hour(s) in category 1 credit of the AMA Physician's Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity. Disclosure Novant Health adhers to NCMS Standards regarding industry support of cointuing medical education, and disclosure of faculty and commercial support relationships, if any, will be made known prior to activity. |
|||
|
©2012 Novant Health: Privacy Statement | HIPAA Notice of Privacy Practices |
|
|
|
|
